RecruitingEarly Phase 1NCT07294092

Ketamine and Propofol NeuroImaging


Sponsor

Keith M Vogt

Enrollment

60 participants

Start Date

Apr 30, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a multi-visit which will collect MRI (pictures of the brain) and EEG (brain waves) data to determine changes in brain connectivity and brain activity for memory formation and pain perception while receiving the commonly-used anesthetic agents ketamine and propofol, both alone and in combination.


Eligibility

Min Age: 18 YearsMax Age: 59 Years

Inclusion Criteria1

  • Adults 18-59 years of age, who:

Exclusion Criteria19

  • have a valid email address and valid phone number throughout the study
  • free from any non-MRI compatible implants
  • are pregnant or attempting to conceive
  • body mass index (BMI) \> 35
  • significant memory impairment or hearing loss
  • sleep apnea
  • chronic pain or frequently taking pain medication
  • chronic medical conditions requiring treatment (hypertension, diabetes, high cholesterol)
  • neurologic disease, including seizures and tremor
  • psychiatric diagnoses, including anxiety, depression, panic, or PTSD
  • a history of any of these medical conditions: abnormal heartbeats (cardiac conduction abnormality or arrhythmia), liver or kidney disease, or significant lung disease
  • severe claustrophobia or intolerance of an MRI
  • have metal implants or non-removable metal piercings
  • having a history of adverse reaction to ketamine or propofol
  • daily alcohol or heavy alcohol use; history of alcohol abuse
  • current daily smoker
  • regular or recent marijuana use (including prescribed/medical marijuana)
  • illicit drug use, i.e., street drugs
  • regularly taking: antiepileptics, antidepressants, anti-psychotics, antihistamines, anti-anxiety medication, stimulants, or sleep-aids

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPropofol

Subjects will receive an intravenous infusion of this drug, during portions of the study.

DRUGKetamine

Subjects will receive an intravenous infusion of this drug, during portions of the study.

DEVICEPeripheral Nerve Stimulation

Experimental acute pain stimulus will be delivered using a nerve stimulator. These painful shocks will be paired with specific experimental events.


Locations(1)

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07294092


Related Trials